Annals of Oncology

NDDO splits from EORTC; A successful cancer march; American pediatric merger spurns Europe; Swiss calculate costs of smoking; Awards, appointments; Perhaps not everyone knows that...; Death toll: 5,000 children a month
pp. 1145-1149(5)

J. G. Geraghty, J. M. Sackier, H. L. Young (eds), Minimal access surgery in oncology
pp. 1150-1150(1)
Author: Laffer U.T.

Primary chemotherapy: A better overall therapeutic option for patients with breast cancer
pp. 1151-1154(4)
Authors: Valero V.; Hortobagyi G.N.

Gene therapy of malignant glioma: Recent advances in experimental and clinical studies
pp. 1155-1166(12)
Authors: Sasaki M.; Plate K.H.

Critical reviews of economic analyses in order to make health care decisions for cancer
pp. 1167-1172(6)
Author: Neymark N.

Staging of breast cancer: What standards should be used in research and clinical practice?
pp. 1173-1177(5)
Authors: Ravaioli A.; Tassinari D.; Pasini G.; Polselli A.; Papi M.; Fattori P.P.; Pasquini E.; Masi A.; Alessandrini F.; Canuti D.; Panzini I.; Drudi G.

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
pp. 1179-1184(6)
Authors: Makris A.; Powles T.J.; Ashley S.E.; Chang J.; Hickish T.; A.Tidy V.; Nash A.G.; Ford H.T.

Thoracic metastasectomy for germ-cell tumours: Long-term survival and prognostic factors
pp. 1185-1191(7)
Authors: Cagini L.; Nicholson A.G.; Horwich A.; Goldstraw P.; Pastorino U.

Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa–N2 non-small-cell lung cancer: A prospective pilot study
pp. 1193-1198(6)
Authors: Vansteenkiste J.F.; Stroobants S.G.; De Leyn P.R.; Dupont P.J.; Verbeken E.K.

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
pp. 1199-1204(6)
Authors: Van Cutsem E.; Pozzo C.; Starkhammar H.; Dirix L.; Terzoli E.; Cognetti F.; Humblet Y.; Garufi C.; Filez L.; Gruia G.; Cote C.; Barone C.

A randomised, concentration-controlled, comparison of standard (5-day) vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer
pp. 1205-1211(7)
Authors: Joel S.; O'Byrne K.; Penson R.; Papamichael D.; Higgins A.; Robertshaw H.; Rudd R.; Talbot D.; Slevin M.

Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma
pp. 1213-1217(5)
Authors: Celsing F.; Widell S.; Merk K.; Bernell P.; Grimfors G.; Hedlund A.; Liliemark J.; Svedmyr E.; Ösby E.; Björkholm M.

Elderly patients with non-Hodgkin's lymphoma: Population-based results in the Netherlands
pp. 1219-1227(9)
Authors: Maartense E.; Hermans J.; Kluin-Nelemans J.C.; Kluin P.M.; Van Deijk W.A.; Snijder S.; Wijermans P.W.; Noordijk E.M.

Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974–1994
pp. 1229-1232(4)
Authors: Levi F.; Randimbison L.; La Vecchia C.

Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial
pp. 1233-1242(10)
Authors: Stupp R.; Bauer J.; Pagani O.; Gerard B.; Cerny T.; Sessa C.; Bastian G.; Sarkany M.; Schläpfer J.; Giroux B.; Leyvraz S.

Abdominal pain with anorexia in patients with breast carcinoma
pp. 1243-1245(3)
Authors: Van Trappen P.; Serreyn R.; Elewaut A.E.; Cocquyt V.; Van Belle S.

A phase I–II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
pp. 1247-1249(3)
Authors: Gelmon K.A.; Tolcher A.; O'Reilly S.; Campbell C.; Bryce C.; Shenkier T.; Ragaz J.; Ayers D.; Nakashima L.; Rielly S.; Dulude H.

D. Buthiau, D. Khayat (eds), CT and MRI in oncology
pp. 1250-1250(1)
Author: Moulopoulos L.A.

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
pp. 1251-1253(3)
Authors: André T.; Louvet C.; Raymond E.; Tournigand C.; de Gramont A.

Prognostic impact of an activation of coagulation in lung cancer
pp. 1255-1255(1)
Author: Watine J.

This letter was referred to the author, who responds as follows
pp. 1255-1256(2)
Author: Seitz R.